IP Library Granted Patent US 8,785,116
Granted Patent B2
US 8,785,116 · App. 13/572,332 · Granted Jul 22, 2014

Methods for evaluating the suitability of an organ for transplant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,785,116
App. No.
13/572,332
Granted
Jul 22, 2014
Kind
B2
Abstract

Methods of determining the health of an organ, such as a transplant organ, by measuring the ex-situ oxygen consumption rate of the organ. Systems for preserving and transporting organs while monitoring viability by measuring oxygen consumption rates.

Claims (13)

1. A method of evaluating the suitability of an organ for transplant comprising:

perfusing the organ at hypothermic temperatures with an oxygenated solution using a mobile perfusion machine comprising a pneumatic system that oxygenates a preservation solution to create the oxygenated solution while varying the pressure of the oxygenated solution with the pneumatic system at least once per minute to create a differential perfusion pressure between about 5 mm Hg to about 30 mm Hg;

measuring the oxygen consumption rate of the organ; and

comparing the measured oxygen consumption rate to a functional oxygen consumption rate, wherein a measured oxygen consumption rate greater than or equal to a functional oxygen consumption rate is indicative of a suitable organ.

2. The method of claim 1 , wherein the functional oxygen consumption rate is greater than or equal to 50 nmo 1 O 2 /min/g of organ mass.

3. The method of claim 1 , wherein the organ is selected from the group consisting of heart, kidney, liver, lung, and pancreas.

4. The method of claim 1 , wherein the organ is perfused at a temperature of less than 10° C.

5. The method of claim 1 , wherein the organ is from an expanded criteria donor (ECD) or from a donation after cardiac death (DCD).

6. The method of claim 1 , additionally comprising monitoring vascular resistance of the organ to perfusion.

7. The method of claim 1 , wherein the mobile perfusion machine varies the pressure on the oxygenated solution at least once every 10 seconds.

8. The method of claim 1 , wherein the mobile perfusion machine additionally comprises one or more oxygen sensors.

9. The method of claim 1 , wherein the mobile perfusion machine oxygenates the preservation solution with a partial pressure of oxygen of at least 100 mmHg (100 Torr).

10. The method of claim 8 , wherein the mobile perfusion machine displays a value indicative of the oxygen consumption rate of the organ.

Assignments (4)
SECURITY INTEREST Recorded May 10, 2022
From: PARAGONIX TECHNOLOGIES, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 059878/0226 →
RELEASE OF SECURITY INTEREST Recorded Oct 7, 2021
From: CAMMETT, JOHN
To: PARAGONIX TECHNOLOGIES, INC.
Reel/Frame 057730/0972 →
SECURITY INTEREST Recorded Feb 18, 2016
From: PARAGONIX TECHNOLOGIES, INC.
To: CAMMETT, JOHN
Reel/Frame 037766/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2012
From: ANDERSON, LISA MARIA; JUDSON, JARED ALDEN
To: PARAGONIX TECHNOLOGIES INC.
Reel/Frame 028953/0397 →